31644-48-1 Usage
General Description
2-amino-N-pyridin-2-ylethanesulfonamide is a chemical compound with the molecular formula C7H10N4O2S. It is a sulfonamide derivative, containing an amino group attached to a pyridine ring and a sulfonamide group. 2-amino-N-pyridin-2-ylethanesulfonamide has been studied for its potential pharmacological properties, including its anti-cancer and anti-inflammatory activities. It is also used as a building block in the synthesis of pharmaceuticals and agrochemicals. 2-amino-N-pyridin-2-ylethanesulfonamide is a versatile chemical with potential applications in various fields, including medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 31644-48-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,4 and 4 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 31644-48:
(7*3)+(6*1)+(5*6)+(4*4)+(3*4)+(2*4)+(1*8)=101
101 % 10 = 1
So 31644-48-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H11N3O2S/c8-4-6-13(11,12)10-7-3-1-2-5-9-7/h1-3,5H,4,6,8H2,(H,9,10)
31644-48-1Relevant articles and documents
Amido pyrimidine compound
-
Paragraph 0327-0329, (2020/06/20)
The invention provides an amido pyrimidine compound with a novel structure as shown in a formula (I) and a preparation method and application of the amido pyrimidine compound. The amido pyrimidine compound is a compound shown as the formula (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer or tautomer thereof and the like. The amido pyrimidine compound provided bythe invention has a relatively good proliferation inhibition effect on various cancer cells; according to the present invention, the compound has characteristics of low tumor cell inhibition concentration, significantly-improved compound activity, good tumor cell selectivity and good solubility, and is expected to be a specific drug for treatment of malignant tumor cell abnormal proliferation diseases caused by EGFR mutation.
